all report title image

NON HODGKINS LYMPHOMA TREATMENT MARKET ANALYSIS

Non-Hodgkins Lymphoma Treatment Market - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI547
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Non Hodgkins Lymphoma Treatment MarketSize and Trends

Non-Hodgkins lymphoma treatment market taxonomy:

On the basis of type of non-hodgkins lymphoma, the non-hodgkins lymphoma treatment market is classified into:

  • B-cell lymphoma
  • T-cell lymphoma

On the basis of end user, the non-hodgkins lymphoma treatment market is classified into:

  • Hospitals
  • Clinics

Increase in incidence of NHL will fuel the market

By geography, North America holds the major share in the market because of the high incidence rate of blood cancers in the U.S. According to Leukemia and Lymphoma Society, non-Hodgkin lymphoma is the seventh most common cancer in the U.S. and fifth in the UK. The National Cancer Institute estimated 72,580 new cases and 20,150 deaths in 2016 due to NHL in the U.S. According to the American Cancer Society, 20 cases of NHL, 6 cases of myeloma and 13 cases of leukemia were estimated per 100,000 population in 2014 in the U.S. Moreover, the organization states that, around 6 out of 10 people diagnosed with non-Hodgkin lymphoma are aged 65 and above. Also, NHL is much more common in men than in women.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.